FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2516648> ?p ?o ?g. }

• W2516648 endingPage "2012" @default.
• W2516648 startingPage "2002" @default.
• W2516648 abstract "We conducted a randomized trial to assess the effectiveness of F-18-fluorodeoxyglucose (FDG) positron emission tomography (PET)-assisted management in patients with severe ventricular dysfunction and suspected coronary disease.Such patients may benefit from revascularization, but have significant perioperative morbidity and mortality. F-18-fluorodeoxyglucose PET can detect viable myocardium that might recover after revascularization.Included were patients with severe left ventricular (LV) dysfunction and suspected coronary disease being considered for revascularization, heart failure, or transplantation work-ups or in whom PET was considered potentially useful. Patients were stratified according to recent angiography or not, then randomized to management assisted by FDG PET (n = 218) or standard care (n = 212). The primary outcome was the composite of cardiac death, myocardial infarction, or recurrent hospital stay for cardiac cause, within 1 year.At 1 year, the cumulative proportion of patients who had experienced the composite event was 30% (PET arm) versus 36% (standard arm) (relative risk 0.82, 95% confidence interval [CI] 0.59 to 1.14; p = 0.16). The hazard ratio (HR) for the composite outcome, PET versus standard care, was 0.78 (95% CI 0.58 to 1.1; p = 0.15); for patients that adhered to PET recommendations for revascularization, revascularization work-up, or neither, HR = 0.62 (95% CI 0.42 to 0.93; p = 0.019); in those without recent angiography, for cardiac death, HR = 0.4 (95% CI 0.17 to 0.96; p = 0.035).This study did not demonstrate a significant reduction in cardiac events in patients with LV dysfunction and suspected coronary disease for FDG PET-assisted management versus standard care. In those who adhered to PET recommendations and in patients without recent angiography, significant benefits were observed. The utility of FDG PET is best realized in this subpopulation and when adherence to recommendations can be achieved." @default.
• W2516648 created "2016-06-24" @default.
• W2516648 creator A5015263586 @default.
• W2516648 creator A5030258702 @default.
• W2516648 creator A5033149493 @default.
• W2516648 creator A5033329191 @default.
• W2516648 creator A5035385558 @default.
• W2516648 creator A5038044357 @default.
• W2516648 creator A5038113976 @default.
• W2516648 creator A5040772609 @default.
• W2516648 creator A5050890781 @default.
• W2516648 creator A5056264770 @default.
• W2516648 creator A5067414342 @default.
• W2516648 creator A5070472491 @default.
• W2516648 creator A5070896042 @default.
• W2516648 creator A5087299074 @default.
• W2516648 creator A5090365672 @default.
• W2516648 date "2007-11-01" @default.
• W2516648 modified "2023-10-01" @default.
• W2516648 title "F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease" @default.
• W2516648 cites W1975487704 @default.
• W2516648 cites W1983813972 @default.
• W2516648 cites W1984640737 @default.
• W2516648 cites W1986223829 @default.
• W2516648 cites W1999879053 @default.
• W2516648 cites W2009758673 @default.
• W2516648 cites W2013549697 @default.
• W2516648 cites W2015828906 @default.
• W2516648 cites W2025102558 @default.
• W2516648 cites W2033798293 @default.
• W2516648 cites W2035667813 @default.
• W2516648 cites W2044518651 @default.
• W2516648 cites W2048222082 @default.
• W2516648 cites W2048834176 @default.
• W2516648 cites W2059283030 @default.
• W2516648 cites W2059707463 @default.
• W2516648 cites W2060099994 @default.
• W2516648 cites W2060273618 @default.
• W2516648 cites W2060845245 @default.
• W2516648 cites W2061105390 @default.
• W2516648 cites W2073370254 @default.
• W2516648 cites W2084847936 @default.
• W2516648 cites W2103108368 @default.
• W2516648 cites W2103269001 @default.
• W2516648 cites W2130907431 @default.
• W2516648 cites W2133148674 @default.
• W2516648 cites W2165183062 @default.
• W2516648 cites W2168907840 @default.
• W2516648 cites W2206091902 @default.
• W2516648 cites W2226558273 @default.
• W2516648 cites W22344235 @default.
• W2516648 cites W4255009698 @default.
• W2516648 cites W1970014205 @default.
• W2516648 doi "https://doi.org/10.1016/j.jacc.2007.09.006" @default.
• W2516648 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17996568" @default.
• W2516648 hasPublicationYear "2007" @default.
• W2516648 type Work @default.
• W2516648 sameAs 2516648 @default.
• W2516648 citedByCount "392" @default.
• W2516648 countsByYear W25166482012 @default.
• W2516648 countsByYear W25166482013 @default.
• W2516648 countsByYear W25166482014 @default.
• W2516648 countsByYear W25166482015 @default.
• W2516648 countsByYear W25166482016 @default.
• W2516648 countsByYear W25166482017 @default.
• W2516648 countsByYear W25166482018 @default.
• W2516648 countsByYear W25166482019 @default.
• W2516648 countsByYear W25166482020 @default.
• W2516648 countsByYear W25166482021 @default.
• W2516648 countsByYear W25166482022 @default.
• W2516648 countsByYear W25166482023 @default.
• W2516648 crossrefType "journal-article" @default.
• W2516648 hasAuthorship W2516648A5015263586 @default.
• W2516648 hasAuthorship W2516648A5030258702 @default.
• W2516648 hasAuthorship W2516648A5033149493 @default.
• W2516648 hasAuthorship W2516648A5033329191 @default.
• W2516648 hasAuthorship W2516648A5035385558 @default.
• W2516648 hasAuthorship W2516648A5038044357 @default.
• W2516648 hasAuthorship W2516648A5038113976 @default.
• W2516648 hasAuthorship W2516648A5040772609 @default.
• W2516648 hasAuthorship W2516648A5050890781 @default.
• W2516648 hasAuthorship W2516648A5056264770 @default.
• W2516648 hasAuthorship W2516648A5067414342 @default.
• W2516648 hasAuthorship W2516648A5070472491 @default.
• W2516648 hasAuthorship W2516648A5070896042 @default.
• W2516648 hasAuthorship W2516648A5087299074 @default.
• W2516648 hasAuthorship W2516648A5090365672 @default.
• W2516648 hasBestOaLocation W25166481 @default.
• W2516648 hasConcept C126322002 @default.
• W2516648 hasConcept C126838900 @default.
• W2516648 hasConcept C164705383 @default.
• W2516648 hasConcept C168563851 @default.
• W2516648 hasConcept C207103383 @default.
• W2516648 hasConcept C2775842073 @default.
• W2516648 hasConcept C2777415128 @default.
• W2516648 hasConcept C2779464278 @default.
• W2516648 hasConcept C2989005 @default.
• W2516648 hasConcept C31174226 @default.

• next